書籍詳細

IV /治療の実際―国際的ガイドラインをも踏まえて―

P.287 掲載の参考文献

• 1) 長岡滋:痰から何が学びとれるか, ライフサイエンス出版, 東京, 1989

• 2) 高橋昭三:気管支喘息の歴史. 医学のあゆみ 159:533-535, 1991
  Medical*Online

• 3) American Thoracic Society Committee on Diagnostic Standards:Definitions and classification of chronic bronchitis, asthma, and pulmonary emphysema. Am Rev Respir Dis 85:762, 1962

• 4) 喘息管理・予防のグローバルストラテジー 喘息管理の国際指針 NHLBI/WHO ワークショップレポート, 牧野荘平日本語訳, 監修, 国際医学出版 (National Heart, Lung and Blood lnstitute, Publication Number 95-3659), 東京, 1995, pp. 1-184

• 5) Global Initiative for Asthma, Global Strategy for Asthma Management and Prevention NHLBI Workshop:GINA 2002<日本語版>, 牧野荘平, 大田健監修, 協和企画, 東京, 2002

• 6) National Asthma Education and Prevention Program:National Asthma Education and Prevention Program Expert Panel Report:Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics-2002. J Allergy Clin Immunol 110 (Suppl):S141-S219, 2002

• 7) The British Thoracic Society:British guideline on the management of asthma. A national clinical guideline, Scottish intercollegiate guidelines network, Edinburgh, 2004, pp. 1-91

• 8) EBM に基づいた喘息治療ガイドライン2004, 宮本昭正監修, 厚生労働科学特別研究事業 診療ガイドラインのデータベース化に関する研究班作成, 協和企画, 東京, 2004, pp. 1-281

• 9) アレルギー疾患治療ガイドライン, 牧野荘平監修, ライフサイエンス・メディカ, 東京, 1993, pp. 1-179

• 10) 喘息予防・管理ガイドライン 2003, 牧野荘平, 古庄巻史, 宮本昭正, 西間三馨監修, 厚生省免疫・アレルギー研究班作成, 協和企画, 東京, 2003, pp. 1-207

• 11) 小児気管支喘息治療・管理ガイドライン 2000, 古庄巻史, 西間三馨監修, 日本小児アレルギー学会作成, 協和企画, 東京, 2000

• 12) 小児気管支喘息治療・管理ガイドライン 2005, 森川昭廣, 西間三馨監修, 日本アレルギー学会作成, 協和企画, 東京, 2005

• 13) Jariwalla G:Epidemiology of asthma and asthma death. In Asthma, ed. by Jariwalla G, MTP Press, Lancaster/Boston, 1988, pp. 11-58

• 14) Gergen PJ et al:Epidemiology. In Current review Of asthma, ed. by Kaliner MA, Current Medicine Inc, Philadelphia, 2003, pp. 1-11

• 15) Magadle R et al:The risk of hospitalization and near fatal and fatal asthma in relation to the perception of dyspnea. Chest 121:329-333, 2002

• 16) Weiss ST:Eat dirt-the hygiene hypothesis and allergic diseases. N Engl J Med 347:930-931, 2002
  pubmed

• 17) Holt PG et al:Functional studies on dendritic cells in the respiratory tract and related mucosal tissues. J Leukoc Biol 66:272-275, 1999
  pubmed

• 18) Holt PG et al:Ia positive dendric cells form a tightly meshed network within the human airway epithelium. Clin Exp allergy 19:597-601, 1989

• 19) Banchereau J et al:Dendritic cells and the control of immunity, Nature 392:245-252, 1998
  pubmed

• 20) Natiorlal Asthma Education and Prevention Program Expert Panel Report 2:Guidelines for the Diagnosis and Management of Asthma, National Institutes of Health (NIH publication no. 97-4051), Bethesda, 1997, pp. 1-146

• 21) Wardlaw AJ et al:Eosinophil. In Bronchial Asthma:Mechanism and therapeutics, ed. by Weiss EB, Stein M, Brown and Company, Boston, 1997, pp. 258-270

• 22) Leckie MJ et al:Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356:2144-2148, 2000
  pubmed

• 23) Terry des Jardins et al:Asthma. In:Clininal manisfestations and Assessment of Respiratory disease, Year Book Medical Publisher, Cicago, 1984, pp. 160

• 24) 矢田純一:イラスト免疫学. メジカルビュー社, 東京, 1990, pp. 78

• 25) Palmer RM et al:Nitric oxide release accounts for the biological activity ofendothelium-derived factor. Nature 327:524-526, 1987

• 26) Moncada S et al:Nitric oxide:physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142, 1991
  pubmed

• 27) Baxter JD et al:Hormone receptors. N Engl J Med 301:1149-1161, 1979
  pubmed

• 28) 武山 廉ほか:EGFR とそのリガンド. 喘息 17:55-59, 2004
  Medical*Online

• 29) Petty TL:The heterogeneous nature of asthma. In:clinical Strategies in Adult Asthma, ed. by Scoggin CH, Petty TL, Lea and Febiger, Philadelphia, 1982, pp. 1-9

• 30) 茆原順一:血管内皮細胞と ICAM-1. 喘息 8:83, 1995

• 31) D Rose V et al:Intercellular adhesion molecule-1 upregulated on peripheral blood T lymphocyte subsets in dual asthmatic responders. J Clin Invest 94:1840-1845, 1994

• 32) Schall TJ et al:Biology of the RANTES/SIS cytokine family. Cytokine 3:165-183, 1991
  pubmed

• 33) Kondo N et al:Genetic defects in down regulation of IgE production and a new genetic classification of atopy. Allerg Intern 53:77-85, 2004

• 34) Tamaoki J:Role of Th2 cytokine inhibitor in asthma treatment. Allerg Intern 53:60, 2004

• 35) Platts-Mills TA et al:Measurement of D. farinae in mite and house dust extracts and in the houses of asthmatic patients. Allergy Clin lmmunol 75:146, 1985

• 36) Terry des Jardins et al:Clinical Manifestation of Respiratory Disease, ed. by Terry DJ, year Book Medical Publishers, Chicago, 1984, pp. 161

• 37) Weitzman M et al:Maternal smoking and childhood asthma. Pediatrics 85:505-511, 1990
  pubmed

• 38) 馬場実:小児アレルギー疾患の発症と展開, 予防と可能性について. アレルギー 38:1061-1069, 1989

• 39) Busse WW et al:Asthma. N Eng J Med 344:350-362, 2001

• 40) Calhoun WJ:Airway Remodelimg in Asthma. In:Current Review of Asthma. ed. by Michael A, Kaliner MA, Crrent Medicine lnc, Philadelphia, 2003, pp. 33-40

• 41) Olivieri D et al:Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma:aplacebo-controlled study. Am J Respir Crit Care Med 155:1864-1871, 1997

• 42) Asthma and hay fever, ed. by Swineford O, Thomas, Springfield, 1971, pp. 1-484

• 43) Rackemann FM:A working classification of asthma. Am J Med 3:601-606, 1947
  pubmed

• 44) Burrows B et al:Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 320:271-277, 1989
  pubmed

• 45) Turner-Warwick M:On observing patterns of airflow obstruction in chronic asthma. Br J Dis Chest 71:73-86, 1977
  pubmed

• 46) O'Byrne PM et al:Late asthmastic responses. Am Rev Resp Dis 136:740-751, 1987

• 47) Woolcock A et al:Thoracic society of Australia and New Zealand. Asthma management plan 1989. Med J Aust 151:650-653, 1989
  pubmed

• 48) 東愛ほか:成人喘息の疫学. 喘息 16:15-19, 2003
  Medical*Online

• 49) 望月博之ほか:喘息の有症率 小児喘息. 喘息 16:21-26, 2003
  Medical*Online

• 50) Asthma:The fact, ed. by Lane DJ, Oxford University Press, New York, 1996, pp. 1-225

• 51) 秋山一男ほか:我が国の気管支喘息の実態調査-小児及び成人喘息-. 国立病院治療共同研究・国立療養所中央研究共同研究報告書, 1998

• 52) 中沢次夫:予後 成人喘息. 喘息 16:27-32, 2003

• 53) 鈴木澤尚美ほか:成人喘息の予後;アンケートによる成人喘息の完解調査. 寛解群と非寛解群の比較検討. アレルギー 50:325, 2001

• 54) Bronnimann S et al:Aprospective study of the natural history of asthma. remission and relapse rates. Chest 90:480-484, 1986

• 55) Suissa S et al:Use of anti-inflammatory therapy and asthma mortality in Japan. Eur Respir J 21:101-104, 2003
  pubmed

• 56) Umetsu DT et al:THI and TH2 CD4+ cells in human allergic diseases. J Allergy Clin Immunol 100:1-6, 1997

• 57) Strachan DP:Hay fever, hygiene, and householed size. BMJ 299:1259-1260, 1989
  pubmed

• 58) Coyle AJ et al:Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia. J Exp Med 181:1229-1233, 1995
  pubmed

• 59) 宮崎広亀ほか:気管支喘息と胃食逆流症. 呼吸と循環 49:553, 2001

• 60) Field SK et al:Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux? a critical review of the literature. Chest 114:275-283, 1998
  pubmed

• 61) Lavietes MH et al:The perception of dyspnea in patients with mild asthma. Chest 120:409-415, 2001
  pubmed

• 62) Li TJ et al:Viral infections and asthma. Ann Allergy 59:321-328, 1987

• 63) Jonsson S et al:Comparison of the oral and intravenous routes for treating asthma with methylprednisolone and theophylline. Chest 94:723-726, 1988
  pubmed

• 64) Griffin E et al:Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. J Allergy Clin lmmunol 87:548-557, 1991

• 65) Calhoun WJ et al:Characteristics of peripheral blood eosinophils in patients with nocturnal asthma. Am Rev Respir Dis 145:577-581, 1992
  pubmed

• 66) Horn BR et al:Total eosinophil counts in the management of bronchial asthma. N Engl J Med 292:1152-1155, 1975
  pubmed

• 67) Ottanelli R et al:Do inhaled corticosteroids affect perception of dyspnea during bronchoconstriction in asthma?Chest 120:770-777, 2001
  pubmed

• 68) Moss RB:Allergy evaluation in children:skin testing and RAST. Am J Asthma Allergy Pediatr 11O:101-108, 1988

• 69) Sherrill DL et al:Longitudinal evaluation of the association between pulmonary function and total serum IgE. Am J Respir Crit Care Med 152:98-102, 1995
  pubmed

• 70) Sears MR et al:Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N Engl J Med 325:1067-1071, 1991
  pubmed

• 71) 牧野荘平ほか:気管支喘息および過敏性肺臓炎における吸入試験の標準法. アレルギー 31:1074, 1982
  Medical*Online

• 72) Twarog FJ:Home monitoring of asthma with peak expiratory flow rates. Ann Allergy 67:457-460, 1991
  pubmed

• 73) Shapiro SM et al:An evaluation of the accuracy of Assess and Mini-Wright peak flow meter, Chest 99:358-362, 1991

• 74) 宮本昭正ほか:日本人のピークフロー値改訂版, 月岡一治監修, 協和企画, 東京, 2002, pp. 1-101

• 75) U. S. Department of Health and Human Services:International consensus report on diagnosis and treatmant of asthma. National Heart, Lung, and Blood Institute, National Institutes of Health. Bethesda, Maryland 20892. Publication no. 92-3091, March 1992. Eur Respir J 5:601-641, 1992

• 76) 滝島任:内科学の進歩, 気道過敏性の臨床. 日本臨床内科医会会誌 76:20, 1987

• 77) 向坂泰夫:安静呼吸による気道抵抗を用いた気道過敏性評価-アセチルコリン吸入試験による検討-. 金沢医科大学雑誌 14:48, 1989

• 78) 桂戴作:心身症治療の概況. 最新医学 38:482, 1983

• 79) 吾郷晋浩:心身医学的にみた気管支喘息の発症. 喘息'91, 牧野荘平監修, メディカルレビュー社, 大阪, 1991, pp. 80

• 80) Miller BD:Depression and asthma:a potentially lethal mixture. J Allergy Clin lmmunol 80:481-486, 1987

• 81) プライム臨床検査・診断指針, 大久保昭行, 吉野谷定美, 北村聖, 松枝啓, 井上博編, 南江堂, 東京, 1996, pp. 413

• 82) Rosenberg M et al:Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 86:405-414, 1977
  pubmed

• 83) Grossman J:One airway, one disease. Chestl 11:11S-16S, 1997

• 84) Guerra S et al:Rhinitis as an independent risk factor for adult-onset asthma. Allergy Clin Immunnol 109:419-425, 2002
  pubmed

• 85) Senior BA et al:Management of sinusitis in the asthmatic patient. Ann Allergy Asthma lmmunol 77:6-15, 1996
  pubmed

• 86) Bresciani M et al:Rhinosinusitis in severe asthma. 」Allergy Clin lmmunol 107:73-80, 2001

• 87) Brinke A et al:Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergv Clin Immunol 109:621-626, 2002
  pubmed

• 88) Busino L et al:Clinical and therapeutic aspects of sinusitis in children with bronchial asthma. Int J Pediatr Otorhinolaryungol 3:287-294, 1981

• 89) Turner ES:Management of the pregnant asthmatic patient. Ann Int Med 93:905-918, 1980
  pubmed

• 90) Oh YM et al:Association between stress and asthma symptoms:a population based study. Respirology 9:363-368, 2004
  pubmed

• 91) Masi AT et al:The Arnerican College of Rheumatology 1990-criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094-1100, 1990
  pubmed

• 92) Fallot RJ:Acute respiratory failure. In:Czarrent Therapy of. Respira to ry Disease, ed. by Cherniack RM, BC Decker, Tronto, 1989, pp. 337-341

• 93) Scoggin CH:Acute asthma and status asthmatics. In:Clinical strategies in adult asthma. ed. by Scoggin CH, Petty TL, Lea and Febiger, Philadelphia, 1982, pp. 34-69

• 94) McFadden ER et al:Arterial-blood gas tension in asthma. N Engl J Med 278:1027-1032, 1968
  pubmed

• 95) Hargreave FE et al:Guidelines for the assessment and treatment of asthma, Allergy Clin lmmunol 85:1098, 1980

• 96) Jardins TR:Asthma. In:Clinical mamfestations Of respiratory disease, ed. by Jardins, Year Book Medical Publishers, Chikago, 1984, pp. 159-186

• 97) Holgate ST et al:喘息の診断, 管理, 転帰. in:Allergy, Part 3, 宮本昭正監訳, Excerpta Medica, Tokyo, 1994, pp. 37-48

• 98) 馬場快彦:じん肺・粉じん作業マニュアル, 労働基準調査会, 東京, 1989, pp. 15

• 99) Newhouse MT et al:Control of asthma by aerosols. N Engl J Med 315:870-874, 1986
  pubmed

• 100) Pritchard JN:The infiuence of lung deposition on clinical response. J Aerosol Medl 4:S19-S26, 2001

• 101) 浅本仁:喘息と薬. Nikkei Medical (1998年12月号):122, 1998

• 102) Newman SP et al:Effect of InspirEase on the deposition of metered-dose aerosols in the human respiratory tract. Chest 89:551-556, 1986
  pubmed

• 103) Newhouse MT (小山弘訳):慢性閉塞性肺疾患における吸入療法-エアロゾルによる呼吸器用薬剤投与の原理とドラッグ・デリバリー・システム-. 最新医学 46:1587, 1992

• 104) Nelson HS:Beta-adrenergic bronchodilator. N Engl J Med 333:499-506, 1995
  pubmed

• 105) Ziment I:Respiratory pharmacology and therapeutics, Saunders, Philadelphia, 1978

• 106) Pearlman DS et al:A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 327:1420-1425, 1992
  pubmed

• 107) 1nman WH et al:Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. Lancet 2:279-285, 1969

• 108) Sears MR et al:Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336:1391-1396, 1990
  pubmed

• 109) Cheung D et al:Long-term effects of a long-acting B2 adenoreceptor agonist salmeterol, 0n airway hyperresponsiveness in patients with mild asthma. N Engl J Med 327:1198-1203, 1992

• 110) Suissa S et al:Acohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med 149:604-610, 1994

• 111) Garrett JE et al:Risk of severe life threatening asthma and β2 agonist type:an example of confounding by severity. Thorax 51:1093-1099, 1996

• 112) 正木拓郎:発作重積状態の治療. 第2回日本アレルギー学会春季臨床集会サテライトシンポジウム記録, メディカルトリビューン, 東京, 1990, pp. 6-9

• 113) Faurschou P et al:Effect of addition of inhaled salmeterol to the treatment of moderate to severe asthmatic uncontrolled on high-dose inhaled steroids. European Respiratory Study group. Eur Respir J 9:1885-1890, 1996

• 114) Greening AP et al:Added salmeteroi versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen&Hanburys Limited UK Study Group. Lancet 344:219-224, 1994

• 115) 坂本芳雄:喘息重症発作の治療. 第2回日本アレルギー学会春季臨床集会サテライトシンポジウム記録, メディカルトリビューン, 東京, 1990, pp. 24-25

• 116) 伊藤幸治ほか:気管支喘息に対する経皮吸収型気管支拡張剤 HN-078 の長期連用時における有効性および安全性の検討. 新薬と臨床 44:581-588, 1995
  Medical*Online

• 117) 堀口高彦ほか:成人気管支喘息患者におけるツロブテロール貼付薬連用による気道炎症及び気道過敏性の推移. 日本呼吸器学会雑誌 42:132-137, 2004
  Medical*Online

• 118) Herrman G et al:Successful treatment of persistent extrema dyspnea "status asthmaticus":use of theophylline ethylene diamine (aminophylline, USP) intravenously. J Lab Clin Med 23:135, 1937

• 119) Barnes PJ:Theophylline. In:Currrent Review of Asthma, ed. by Michael A, Kaliner MA, Current Medicine Inc, Philadelphia, 2003, pp. 173-184

• 120) Bukowskyi M et al:Theophylline reassessed. Ann lntern Med 101:63-73, 1984

• 121) Persson CG et al:Pharmacology of anti-asthma xanthines. In:Pharmacology of asthma, ed. by Alexander AG, Page CP, Barnes PJ, Springer-Verlag, New York, 1991, pp. 207-225

• 122) Weinberger M et al:Theophylline in asthma. N Engl J Med 334:1380-1388, 1996
  pubmed

• 123) Rachelefsky GS et al:Behaviour abnormalities and poor school performance due to theophylline use. Pediatrics 78:1133-1138, 1986
  pubmed

• 124) 阿部裕樹ほか:Theophylline 関連けいれんに対する初期治療効果の検討. 日本小児呼吸器疾患学会雑誌 107:1356-1360, 2003

• 125) Rivington RN et al:Efficacy of Uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids. Am J Respir Crit Care Med 151:325-332, 1995
  pubmed

• 126) 大橋裕二ほか:喘息の吸入療法-抗コリン薬. 吸入療法の進歩, 江頭洋祐, 宮城征四郎編, メディカルレビュー社, 大阪, 1989, pp. 65-72

• 127) Stoodley RG et al:The role of ipratropium bromide in the emergency management of acute asthma exacerbation:ameta-analysis of randomized clinical trials. Ann Emerg Med 34:8-18, 1999

• 128) 一ノ瀬正和:チオトロピウム. 分子呼吸器病 8:78-80, 2004

• 129) Mountain RD et al:Clinical features and outcome in patients with acute asthma presenting with hypercapnia. Am. Rev Respir Dis 138:535-539, 1988
  pubmed

• 130) Trigg CJ et al:Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Medl 50:17-22, 1994

• 131) Boushey HA:Relationship of asthma severity to fatalities. In:Fatal Asthma, ed. by Sheffer AL, Marcel Dekker, New York, 1998, pp. 363-385

• 132) Barnes PJ:Inhaled glucocorticoids for asthma. N Engl J Med 332:868-875, 1995
  pubmed

• 133) Beasley R et al:International trends in asthma mortality. Ciba Found Symp 206:140-150, 1997
  pubmed

• 134) Wennergren G et al:Decrease in hospitalization for treatment of childhood asthma with increased use of antiinflammatory treatment, despite an increase in prevalence of asthma. J Allergy Clin lmmunol 97:742-748, 1996

• 135) Ernst P et al:Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA 268:3462-3464, 1992
  pubmed

• 136) Campbell MJ et al:Age specific trends in asthma mortality in England and Wales, 1983-1995:results of an observational study. BMJ 314:1439-1441, 1997
  pubmed

• 137) 稲垣直樹ほか:吸入ステロイド療法の作用機序. 喘息 17:17-22, 2004
  Medical*Online

• 138) Barnes PJ et al:Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med 157:Sl-S53, 1998

• 139) Gold R et al:Mechanism of action of glucocorticosteroid hormones:possible implications for therapy of neuroimmunological disorders. J Neuroimmnunol 17:1-8, 2001

• 140) Evans PM et al:Effect of inhaled corticosteroids on peripheral blood eosinophilcounts and density profiles in asthma. J Allergy Clin Jmmunol 91:643-650, 1993

• 141) Cohan VL et al:Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin. Am Rev Respir Dis 140:951-954, 1989
  pubmed

• 142) オーストラリア治療ガイドライン委員会:喘息の長期的薬物治療. 呼吸器疾患治療ガイドライン, 別府宏圀, 豊島協一郎, 吉田聡, 浜六郎監訳, NPO法人医薬ビジランスセンター, 大阪, 2001, pp. 97-115

• 143) Brunette MG et al:Childhood asthma:prevention of attacks with short-term corticosteroid treatment of upper respiratory tract infection. Pediatrics 81:624-629, 1988
  pubmed

• 144) Greenberger PA:Corticosteroids in asthma. Rationale, use, and problems. Chest 101:418S-421S, 1992
  pubmed

• 145) 浅本仁:膠原病における免疫学的治療の現状, ステロイド離脱の実際と注意点. 臨床と薬物治療 6:359-363, 1987

• 146) 勝正孝ほか:副腎皮質ステロイド剤の作用と使い方, 日本アップジョン KK, 東京, 1983

• 147) Spector SL:Practice parameters for the deagnosis and treatment of asthma. Allergy Clin Immunol 96:707-870, 1995

• 148) Gottlieb DJ et al:Poverty, race, and medication use are correlates of asthma hospitalization rates. A small analysis in Boston. Chest 108:28-35, 1995

• 149) Selroose O:Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 108:1228-1234, 1995

• 150) Haahtela T:Effects of reducing or discontinuing inhaled budesonide in patients withmild asthma. N Engl J Med 331:700-705, 1994

• 151) Pederson S:Can steroids cause asthma to remit? Am J Respir Crit Care Med 153:S31-S32, 1996

• 152) Kerrebijn KF et al:Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. Allergy Clin Immunol 79:653-659, 1987
  pubmed

• 153) Gaddie J et al:Aerosol beclomethasone dipropionate:a dose-response study inchronic bronchial asthma. Lancet 2:280-281, 1973

• 154) Donahue JG:Inhaled steroids and the risk of hospitalization for asthma, JAMA 277:887-891, 1997
  pubmed

• 155) Van Essen-Zandvliet EE et al:Effects of 22 months of treatment with inhaled corticosteroids and or beta2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronis Non-specific Lung Disease Study Group. Am Rev Respir Dis 146:547-554, 1992

• 156) Powell H et al:Inhaled corticosteroid doses in asthma:an evidence-based approach. Med J Aust 178:223-225, 2003
  pubmed

• 157) 宮川武彦:吸入ステロイド薬の選択に関する考察. 医薬ジャーナル 40:134-141, 2004

• 158) Barnes NC et al:Clinical experience with fluticasone proprionate in asthma:ameta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionqte at half the microgram dose or less. Respir Med 92:95-104, 1998

• 159) Hoekx JC et al:Fluticasone propionate compared with budesonide:adouble-blindtrial in asthmatic children using powder devices at a dosage of 400ug/day (-1). Eur Respir J 9:2263-2272, 1996

• 160) 藤村直樹:新しい超微粒子エアゾール吸入ステロイド薬HFA-BDP (キュバール). アレルギーの臨床 22:623-628, 2002

• 161) Turnar-Warwick M:Epidemiology of nocturnal asthma. Am J Med 85:6-8, 1988

• 162) Postma DS et al:Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening. Eur Respir J 17:1083-1088, 2001
  pubmed

• 163) New Drugs and Profile Report:Inhaled mometasone furoate:a point corticosteroid for the treatment of asthma. Drugs Ther Perspect 18:1-3, 2002

• 164) Harrison TW et al:Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations:randomized controlled trial. Lancet 363:271-275, 2004
  pubmed

• 165) Balfour-Lynn L:Growth and childhood asthma. Arch Dis Child 61:1049-1055, 1986
  pubmed

• 166) Tinkelman DG et al:Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 92:64-77, 1993
  pubmed

• 167) Allen DB et al:Ameta-analysis of the effect of oral and inhaled corticosteroids on growth. Allergy Clin lmmunol 93:967-976, 1994

• 168) Todd GR et al:Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 87:457-461, 2002
  pubmed

• 169) Cumming RG et al:Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 337:8-14, 1997
  pubmed

• 170) Carbe E et al:lnhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA 277:722-727, 1997
  pubmed

• 171) Pauwels RA et al:The inhaled Steroid Treatment as Regular Therapy in early asthma (START) study:rationale and design. Control Clin Trials 22:405-419, 2001
  pubmed

• 172) Fukushima C et al:Oral candidiasis associated with inhaled corticosteroid use:comparison of fluticasone and beclomethasone. Ann Allergy Asthma Immunol 90:646-5L 2003
  pubmed

• 173) Alvarez J et al:Steroid-resistant asthma:immunologic and pharmacologic features. Allergy Clin Immunol 89:714-721, 1992
  pubmed

• 174) Spector SL et al:Practice parameter for the diagnosis and treatment of asthma. J Allergy Clin Immunol 96:174-181, 1995

• 175) Barnes PJ et al:Glucocorticoid resistance in asthma. Am J Respir Cirt Care Med 152:S125-S140, 1995

• 176) Ogirala RG et al:Single, high-dose intramuscular triamcinolone acetonide versusweekly oral methotrexate in life-threatening asthma:a double-blind study. Am J Respir Crit Care Med 152:1461-1466, 1995
  pubmed

• 177) 石原享介:吸入ステロイド治療を中心とする喘息外来の実態と問題点. 日本臨牀 54:2976-2981, 1996
  Medical*Online

• 178) Matsunaga K et al:Effect of a leukotriene receptor antagonist on the prevention ofrecurrent asthma attacks after an emergency room visit. Allergology International 53:341-347, 2004

• 179) Taniguchi Y et al:The effect of an oral leukotrien antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjects. J Allergy Clin Immunol 92:507-512, 1993
  pubmed

• 180) Minoguchi K et al:Reduction of eosinophilic inflammation in the airway of patientswith asthma using montelukast. Chest 121:732-738, 2002

• 181) Munoz NM et al:Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade andleukotriene receptor antagonism. Am J Respir Crit Care Med 155:1398-1403, 1997
  pubmed

• 182) Bateman ED et al:Amulticentre study to assess the steroid-sparing potential of Accolade (zafirlukast; 20mg bd). Allergy 50:320, 1995

• 183) Nakamura Y et al:Effect of the leukotriene receptor antagonist pranlukast oncellular infiltration in the bronchial mucosa of patients with asthma. Thorax 53:835-841, 1998
  pubmed

• 184) Henderson WR Jr et al:Arole for cysteinyl leukotriens in airway remodeling in amouse asthma model. Am J Respir Crit Care Med 165:108-116, 2002

• 185) Drazen JM et al:Treatment of asthma with drugs modifying the leukotriene pathway, N Engl J Med 340:197-206, 1999
  pubmed

• 186) Peters-Golden M et al:Cysteinyl leukotriene interactions with other mediators andwith glucocorticosteroids during airway inflammation. J Allergy Clin Immunol 111:S37-S42, 2003

• 187) Bjermer L et al:Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults:one year, double blind, randomised, comparative trial. BM 1327:891, 2003

• 188) Crystal-Peters J et al:Treating allergic rhinitis in patients with comorbid asthma:the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 109:57-62, 2002
  pubmed

• 189) Braunstahl GJ et al:Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 164:858-865, 2001296

• 190) Bjermer L:History and future perspectives of treating asthma as a systemic and small airways disease. Respir Med 95:703-719, 2001
  pubmed

• 191) Price DB et al:Randomised controlled trial of montelukast plus inhaled budesonideversus double inhaled budesonide in adult patients with asthma. Thorax 58:211-216, 2003
  pubmed

• 192) Steinke JW et al:Cysteinyl leukotrien expression in chronic hyperplastic sinusitisnasal polyposis:importance to eosinophilia and asthma. J Allergy Clin Immunol 111:342-349, 2003
  pubmed

• 193) Knorr B et al:Montelukast for chronic asthma in 6-to 14-year-old children:a randomized, double-blind trial. JAMA 279:1181-1186, 1998
  pubmed

• 194) Bisgaard H et al:A randomized trial of montelukast in respiratory syncytial viruspostbronchiolitis. Am J Respir Crit Care Med 167:379-383, 2003

• 195) Ferreira MB et al:Leukotriene receptor antagonists (Montelukast) in the treatmentof asthma crisis:preliminary results of a double-blind placebo controlled randomizedstudy. Allerg Immunol 33:315-318, 2001

• 196) Sampson AP et al:Variant LTC (4) synthase allele modifies cysteinyl leukotrienesynthesis in eosinophils and predicts clinical response to zafirlukast. Thorax 55:S28-S31, 2000

• 197) Nelson HS et al:Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. Allergy Clin lmmunol 106:1088-1095, 2000
  pubmed

• 198) Fish JE et al:Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy. Chest 120:423-430, 2001
  pubmed

• 199) Ringdal N et al:The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma. Respir Med 97:234-241, 2003
  pubmed

• 200) Vaquerizo MJ et al:Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax 58:204-210, 2003
  pubmed

• 201) Nayak AS et al:Equivalence of adding zafirlukast versus double-dose inhaled corticosteroids in asthmatic patients symptomatic on low-dose inhaled corticosteroids. J Allergy Clin Immunol 101:S233, 1998

• 202) Virchow JC et al:Improved asthma control over 6 weeks with zafirlukast in patients on high dose inhaled corticosteroids. Eur Respir J10:437S, 1997

• 203) O' Shaughnessy KM et al:Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotrien E4 excretion. Am Rev Respir Dis 147:1472-1476, 1993
  pubmed

• 204) Edelman JM et al:Oral montelukast compared with inhaled salrneterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Ann Intern Med 132:97-104, 2000297

• 205) Evans DJ et al:A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 337:1412-1418, 1997

• 206) Bateman ED et al:Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Am J Respir Crit Care Med 170:836-844, 2004
  pubmed

• 207) 中川武正:抗アレルギー薬の行くべき道. アレルギー 53:653-654, 2004
  Medical*Online

• 208) Petty TL et al:Cromolyn sodium is effective in adult chronic asthmatics. Am Rev Respir Dis 139:694-701, 1989
  pubmed

• 209) Konig P et al:The effect of drug therapy on long-term outcome of childhood asthma:A possible preview of the international guidelines. J Allergy Clin lmmunol 98:1103-1111, 1996

• 210) Lowhagen O et al:Modification of bronchial hyperreactivity after treatment with sodium cromoglycate during pollen season. J Allergy Clin Immunol 75:460-467, 1985

• 211) Hosino M et al:The effect of inhaled sodium cromoglycate on cellular infiltration into the bronchial mucosa and the expression of adhesion molecules in asthmatics. Eur Respir J 10:858-865, 1997

• 212) Myou S et al:Additive effect of cysteinyl leukotriene or thromboxane modifiers to inhaled corticosteroids in asthmatic patients. Allergology International 53:211-217, 2004

• 213) Sano Y et al:Effects of suplatast tosilate, on allergic eosinophilic airway inflammation in patients with mild asthma. A Allergy Clin Immunol 111:958-966, 2003
  pubmed

• 214) Busse WW et al:Corticosteroid-sparing effect of azelastine in the management of bronchial asthma. Am J Respir Care Med 153:122-127, 1996

• 215) 工藤翔二:びまん性汎細気管支炎に対するエリスロマイシン少量長期投与の臨床効果に関する研究-4年間の治療成績-. 日本胸部疾患学会誌 25:632-642, 1987

• 216) Kudo K et al:Low-dose and long-term erythromycin therapy in SBS, asthma. Sarcoidosis 9:637-640, 1992

• 217) Amayasu H et al:Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. Ann Allergy Asthma Immunol 84:594-598, 2000
  pubmed

• 218) 大塚恭男ほか:漢方医学, 杵渕彰編, 財団法人日本漢方医学研究所, 東京, 1990, pp.

• 219) 松田邦夫:気管支喘息. 漢方医学, 杵渕彰編, 財団法人日本漢方医学研究所, 東京, 1990, pp. 88-91

• 220) Dudan A:Sodium gold thiosulfate in bronchial asthma. Schweiz Med Wochenschr 62:96, 1932

• 221) 木村郁郎ほか:気管支喘息の根治療法-金療法. 喘息 1:43-38, 1989

• 222) 宮本昭正ほか:成人気管支に対するオーラノフィンの臨床評価-多施設二重盲検比較試験-. 薬理と治療 20:1249-1278, 1992

• 223) 本間正明:非特異的気道過敏性に及ぼすオーラノフィンの影響:アレルギー 40:1470-1476, 1991
  Medical*Online

• 224) Pavord I et al:The effect of inhaled heparin on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma. Eur Respir J 9:217-219, 1996
  pubmed

• 225) 谷崎勝昭ほか:気管支喘息におけるヘパリン療法の臨床的検討. 日本胸部疾患学会誌 21:988-922, 1983

• 226) Munyard P et al:Inhaled frusemide and exercise-induced bronchostriction in children with asthma. Thorax 50:677-679, 1995

• 227) Mullarkey MF et al:Long-term methotrexate treatment in corticosteroid-dependent asthma. Ann lntern Med 112:577-581, 1990
  pubmed

• 228) Erzurum SC et al:Lack of benefit of methotrexate in severe, steroid-dependent asthma. A double-blind, placebo-controlled study. Ann Intern Med 114:353-360, 1991
  pubmed

• 229) 福田健:第47回米国アレルギー学会, Congress Report. 呼吸器, 福地義之助ほか編, ライフサイエンス出版, 東京, 1991, pp. 1-3

• 230) Rowe BH et al:Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2:CDOO 1490, 2000

• 231) Takao A et al:Inhibitory effects of azelastine hydrochloride in alcohol-induced asthrna. Ann Allergy Asthma Immunol 82:390-394, 1999
  pubmed

• 232) Weinberger M. The value of theophylline for asthma. Ann Allergy 63:1-3, 1989
  pubmed

• 233) Darioli R et al:Mechanical controlled hypoventilation in status asthmaticus. Am Rev Respir Dis 129:385-387, 1984
  pubmed

• 234) Pierson DJ et al:Mechanical ventilation in acute severe asthma:practical management. In:A bstracts of Fozarth Congress Of Asia Pactfic Association for Respiratory Care, Nagoya, Japan, 1995, pp. 1-9

• 235) Hodgkin JE:Techniques of ventilator weaning. In:Respiratory Care, ed. by Burton GG, Hodgkin JE, Lippincott company, Philadelphia, 1984, pp. 648-655

• 236) Freeman J:Further observation on the treatment of hay fever by hypodermicinoculations of pollen vaccine. Lancet 1:814-817, 1911

• 237) 牧野荘平:特異的療法. アレルギーの治療, 山村雄一, 信太隆夫編, メディカルトリビューン, 東京, 1983, pp. 160-168

• 238) 久保木富房:難治性喘息-心身医学的治療. Pharma Medica 5:92-95, 1987

• 239) 清水巍:去痰のやり方. みんなで治す喘息大学, 合同出版, 東京, 1985, pp. 161-164

• 240) 岡和孝:ヨガ療法. 心身医学, 診療内科オリエンテイションレクチャー, 中川哲也監修, 九州大学医学部診療内科編, 1988, pp. 387-392

• 241) Miyagi S et al:A trial of home oxygen for acute asthma attacks for the prevention of asthmatic deaths. Allergology lnternational 54:31-34, 2005

• 242) Hunt LW et al:Asthma-producing drugs. Ann Allergy 68:453-462, 1992
  pubmed

• 243) Szczeklik A et al:Hydrocortisone and airflow impairment in aspirin-induced asthma. J Allergy Clin Immunol 76:530-536, 1985
  pubmed

• 244) 末次勤:重症喘息とアスピリン. Excerpta Medica NewsLetter Allergy update 1:16, 1990

• 245) Szczeklik A et al:Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-induced Asthma. Eur Respir J 16:432-436, 2000
  pubmed

• 246) 浅本 仁ほか:非ステロイド系抗炎症薬による致死的喘息発作症例の検討. 日本アレルギー学会誌 48:1230-1237, 1999

• 247) Sampson AP et al:Profound overexpression of leukotriene C4 synthase in bronchial biopsies from aspirin-intolerant asthmatic patients. Int Arch Allergy Immunol 113:355-357, 1997
  pubmed

• 248) Stevenson DD:Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 74:617-622, 1984
  pubmed

• 249) Szczeklik A et al:Genetic mechanisms in aspirin-induced asthma. Am J Respir Crit Care Med 161:S142-S146, 2000
  pubmed

• 250) Kawagishi Y et al:Leukotrien C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma. J Allergy Clin lmmunol 109:936-942, 2002

• 251) 末次勤:解熱鎮痛剤過敏性喘息に関する臨床的研究-その臨床像を中心として-. 京都大学胸部疾患研究所紀要 15:43, 1982

• 252) 佐賀勤ほか:アスピリン喘息における誘発試験の研究-吸入負荷を中心として. アレルギー 26:85, 1977

• 253) 末次勤ほか:アスピリン喘息および関連疾患. 臨床科学 26:1265, 1990

• 254) Pleskow WW et al:Aspirin desensitization in aspirin-sensitive asthmatic patients:clinical manifestations and characterization of the refractory period. J Allergy Clin lmmunol 69:11-19, 1982

• 255) Katz RM:Exercise-induced asthma. How to complete in sports. Am J Asthma and Allergy 1:71-74, 1988

• 256) Carlsen KH et al:Overnight protection by inhaled salmeterol on exercise-induced asthma in children. Eur Respir J 8:1852-1855, 1995
  pubmed

• 257) Leff JA et al:Montelucast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 339:147-152, 1998

• 258) Coreno A et al:Comparative effects of long-acting beta2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma. J Allergy Clin Immunol 106:500-506, 2000

• 259) Blanc P:Occupational asthma in a national disability survey. Chest 92:613-617, 1987

• 260) Chan-Yeung M et al:Occupational asthma. N Engl J Med 333:107-112, 1995
  pubmed

• 261) 佐藤一博ほか:職業性喘息. 喘息 16:45-54, 2003
  Medical*Online

• 262) 中村晋:職業と気管支喘息. 気管支喘息とその周辺, 宮本昭正, 植田穣編, 医歯薬出版, 東京 1982, pp. 293

• 263) 城智彦:減感作療法-職業性喘息と減感作療法-. 喘息 1:37-41, 1989

• 264) 渡辺尚:アルコール (飲酒) 誘発喘息の発症機序に関する研究-特にアセトアルデヒドとの関連について-. アレルギー 40:1210, 1991

• 265) 藤村政樹:慢性咳嗽の定義と基礎病態. 慢性咳嗽を診る, 藤村政樹編, 医薬ジャーナル社, 大阪, 2002, pp. 1-27

• 266) Irwin RS et al:Postnasal drip and cough. Clin Notes Respir Disl 8:11-12, 1980

• 267) Gibson PG et al:Chronic cough:eosinophilic bronchitis without asthma. Lancet 17:1346-1348, 1989

• 268) Irwin RS et al:Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 41:640-647, 1990
  pubmed

• 269) Morice AH et al:The diagnosis and management of chronic cough. Eur Respir J 24:481-492, 2004
  pubmed

• 270) Glauser FL:Variant asthma. Ann Allergy 30:457-459, 1972
  pubmed

• 271) McFadden ER Jr:Exertional dyspnea and cough as preludes to acute attacks of bronchial asthma. N Engl J Med 292:555-559, 1975
  pubmed

• 272) Corrao WM et al:Chronic cough as the sole presenting manifestation of bronchial asthma. N Engl J Med 300:633-637, 1979
  pubmed

• 273) 藤村政樹:医学と医療の最前線, 咳喘息とアトピー咳. 日本内科学会雑誌 93:1200-1205, 2004

• 274) Irwin RS et al:Managing cough as a defense mechanism and as a symptom A consensus panel report of the American College of Chest Physicians. Chest 114:133S-181S, 1998
  pubmed

• 275) 浅本 仁ほか:Pranlukastの気道過敏性改善効果について-体プレチスモグラフ (BX-82) を用いて-. PROGRESS IN MEDICINE 21:1761-1766, 2001
  Medical*Online

• 276) 久保裕一ほか:ストレス性咳嗽に対する麦門冬湯の影響. 漢方と免疫・アレルギー 15:91-101, 2001

• 277) National Heart, Lung, and Blood Institutes:NAEPP expert panel report:Managing asthma during pregnancy:recommendations for pharmacologic treatment-2004 update. J Allergy Clin Immunol 115:34-46, 2005

• 278) Wendel PJ et al:Asthma treatment in pregnancy:a randomized controlled study. Am J Obstet Gynecol 175:150-154, 1996
  pubmed

• 279) Mawhinney H et al:Optimum management of asthma in pregnancy. Drugs 32:178-187, 1986
  pubmed

• 280) Lenfant C et al:Management of asthma during pregnancy. In:National Asthma Education Program, ed. by National Institutes of Health, Life Science Pub, Bethesda, 東京, 1994, pp. 1-37

• 281) Hesselmar B et al:Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy 29:611-617, 1999
  pubmed

• 282) 日本呼吸器学会COPDガイドライン第2版作成委員会:[2] 安定期の管理, COPD (慢性閉塞性肺疾患) 診断と治療のためのガイドライン, 日本呼吸器学会, メディカルレビュー社, 東京, 2004, pp. 68-76

• 283) Pauwels RA et al:Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med 340:1948-1953, 1999
  pubmed

• 284) Vestbo J et al:Long-term effect of inhaled budesorlide in mild and moderate chronic obstructive pulmonary disease:arandomised controlled trial. Lancet 353:1819-1823, 1999
  pubmed

• 285) Burge PS et al:Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease:the ISOLDE trial. BMJ 320:1297-1303, 2000

• 286) Lung Health Study Research Group:Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 343:1902-1909, 2000

• 287) Briggs DD Jr et al:Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD. Pulm Pharmacol Ther 18:397-404, 2005
  pubmed

• 288) Brusasco V et al:Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax 58:399-404, 2003
  pubmed

• 289) Donohue JF et al:A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol.Chest 122:47-55, 2002
  pubmed

• 290) Cazzola M et al:The functional impact of adding salmeterol and tiotropium in patients with stable COPD. Respir Med 98:1214-1221, 2004
  pubmed

• 291) 浅本 仁ほか:非ステロイド系抗炎症薬による致死的喘息症例の臨床的検討. アレルギー 48:1230-1237, 1999

• 292) Sheffer A:Death due to asthma. Allergology lnternational 45:67, 1996

• 293) 中沢次夫:わが国の喘息死の動向. アレルギア 33:1-3, 2004

• 294) Pearce N et al:End of the New Zealand asthma mortality epidemic. Lancet 345:41-44, 1995
  pubmed

• 295) Strunk RC:Death caused by asthma:minimizing the risks. J Resp 10:21-36, 1989

• 296) Cochrane GM:喘息の疫学. In:A color atlas of asthma. Bristol-Myers Squibb KK, Tokyo, 1989, pp. 1-6

• 297) Westerling R:Studies of avoidable factors influencing death:a call for explicit criteria. Qual Health Care 5:159-165, 1996

• 298) Wasserfallen JB et al:Sudden asphyxic asthma:a distinct entity? Am Rev Respir Dis 142:108-111, 1990
  pubmed

• 299) 須藤守夫:気管支喘息. 呼吸と循環 43:845, 1995

• 300) Leckie MJ et al:Effects of an interleukin-5 blocking monoclonal antibody one osinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 356:2144-2148, 2000

• 301) Borish LC et al:Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. Am J Respir Crit Care Med 160:1816-1823, 1999
  pubmed

• 302) Busse W et al:Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 108:184-190, 2001
  pubmed

• 303) 永田 真:アレルゲン免疫療法の現状と展開. 日本内科学会雑誌 94:152-156, 2005303

患者さんが知りたい気管支喘息Q&A

P.317 掲載の参考文献

• 1) Harrison TW et al:Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations:randornised controlled trial. Lancet 363:271-275, 2004
  pubmed

• 2) Guerra S et al:Rhinitis is an independent risk factor for developing cough apart from colds among adults. Allergy 60:343-349, 2005
  pubmed